Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03922542 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparison of Standard vs. Accelerated Corneal Crosslinking

StatusCompleted
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 6 more changesShow less
    • Enrollment target: estimated 510 to confirmed 508
    • Primary completion date changed from estimate of Jun 1, 2026 to Jun 30, 2026
    • Study completion date changed from estimate of Jul 1, 2026 to Jun 30, 2026
    • Eligibility criteria expanded, about 7 words
    • Site details revised
    • Publications: details revised at 3 of 3 entries
  2. Re-verified, no change to tracked fieldsv9
  3. Primary completion date: May 1, 2026 to Jun 1, 2026
    • Study completion date: May 1, 2026 to Jul 1, 2026
    v8
  4. 2 versions Re-verified since Jan 6, 2023, no change to tracked fieldsv6-v7
  5. Primary completion date: Apr 1, 2026 to May 1, 2026v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Apr 1, 2025 to Apr 1, 2026
    • Study completion date: May 1, 2025 to May 1, 2026
    v4
  2. 2 versions Re-verified since Dec 16, 2019, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.
Trial Details
NCT Number NCT03922542
Lead Sponsor Price Vision Group
Conditions
(from sponsor)		 Keratoconus, Ectasia Corneal
Related terms Keratoconus
Enrollment 508 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov